{"version":"1.0","provider_name":"Canadian Drug Policy Coalition","provider_url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/","author_name":"admin","author_url":"https:\/\/mail.canadiandrugpolicy.ca\/fr\/author\/admin\/","title":"Qu\u2019est-ce que la naloxone? - Canadian Drug Policy Coalition","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"QgU5knJ1cV\"><a href=\"https:\/\/mail.canadiandrugpolicy.ca\/fr\/quest-ce-que-la-naloxone\/\">Qu\u2019est-ce que la naloxone?<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/mail.canadiandrugpolicy.ca\/fr\/quest-ce-que-la-naloxone\/embed\/#?secret=QgU5knJ1cV\" width=\"600\" height=\"338\" title=\"&#8220;Qu\u2019est-ce que la naloxone?&#8221; &#8212; Canadian Drug Policy Coalition\" data-secret=\"QgU5knJ1cV\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/mail.canadiandrugpolicy.ca\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","thumbnail_url":"https:\/\/mail.canadiandrugpolicy.ca\/wp-content\/uploads\/2015\/01\/CDPC_NaloxoneMultiple_Blog_415x415px-S.jpg","thumbnail_width":415,"thumbnail_height":415,"description":"La naloxone est un compos\u00e9 chimique s\u00e9curitaire et tr\u00e8s efficace qui inverse les effets des opiac\u00e9s comme l\u2019h\u00e9ro\u00efne. Depuis 40 ans, elle est utilis\u00e9e dans des milieux cliniques comme traitement d\u2019urgence contre les surdoses d\u2019opiac\u00e9s. Aux \u00c9.-U. et en Europe, les programmes \u00ab\u00a0Take Home Naloxone\u00a0\u00bb ont \u00e9t\u00e9 associ\u00e9s \u00e0 des r\u00e9ductions de jusqu\u2019\u00e0 34\u00a0% des [&hellip;]"}